Skip to main content
Clinical Trials/NCT03244137
NCT03244137
Completed
Not Applicable

Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease

ADIR Association2 sites in 1 country56 target enrollmentSeptember 4, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease
Sponsor
ADIR Association
Enrollment
56
Locations
2
Primary Endpoint
Baseline cognitive function
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Chronic obstructive pulmonary disease is a leading cause of mortality worldwide.

It is a systemic disease which includes pulmonary, cardiac, muscular, digestive and cognitive impairments.

Pulmonary rehabilitation is a symptomatic treatment to reduce dyspnea and functional incapacity. However, it effects on cognitive dysfunction are not well known.

The aim of this study is to assess the effects of a comprehensive pulmonary rehabilitation program on cognitive dysfunction in patients with severe to very severe chronic obstructive pulmonary disease using the Montreal Cognitive Assessment tool.

Registry
clinicaltrials.gov
Start Date
September 4, 2017
End Date
December 1, 2019
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
ADIR Association
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age \> 18years;
  • Chronic obstructive pulmonary disease stade III to IV;
  • Referred for pulmonary rehabilitation.
  • Non Inclusion Criteria:
  • Pregnancy or likely to be;
  • History of psychiatric, neuro-vascular, cognitive disease or cranial trauma;
  • Active alcoholism;
  • Guardianship;
  • Hospitalisation for acute exacerbation of chronic obstructive pulmonary disease in the previous 4 weeks;

Exclusion Criteria

  • Interruption of the pulmonary rehabilitation program \> 15 days;
  • Disruption of the training before the 18th session;
  • Less than 18 sessions in four month.

Outcomes

Primary Outcomes

Baseline cognitive function

Time Frame: Cognitive function is assessed at the beginning of the rehabilitation program : day 0

Cognitive function is assessed with the Montreal Cognitive Assessement tool

Cognitive function after pulmonary rehabilitation

Time Frame: Cognitive function is assessed at the end of the rehabilitation program : day 60

Cognitive function is assessed with the Montreal Cognitive Assessement tool

Cognitive function : follow up

Time Frame: Cognitive function is assessed 3 month after rehabilitation : day 150

Cognitive function is assessed with the Montreal Cognitive Assessement tool

Change in cognitive function from baseline to the end of pulmonary rehabilitation

Time Frame: Change in cognitive function from baseline to the end of pulmonary rehabilitation is assessed with end of pulmonary rehabilitation minus baseline values (day 60 - day 0)

Cognitive function is assessed with the Montreal Cognitive Assessement tool

Change in cognitive function from the end of pulmonary rehabilitation to 3 month of follow up

Time Frame: Change in cognitive function from the end of pulmonary rehabilitation to 3 month of follow up is assessed with the 3 month of follow minus the end of pulmonary rehabilitation values (day 150 - day 60)

Cognitive function is assessed with the Montreal Cognitive Assessement tool

Secondary Outcomes

  • Functional capacity (six-minute stepper test) : baseline(Functional capacity is assessed at the beginning of the rehabilitation program : day 0)
  • Functional capacity (six-minute stepper test) : end of pulmonary rehabilitation(Functional capacity is assessed at the end of the rehabilitation program : day 60)
  • Anxiety and depression : end of pulmonary rehabilitation(Anxiety and depression are assessed at the end of the rehabilitation program : day 60)
  • Quality of life : end of pulmonary rehabilitation(Quality of life is assessed at the end of the rehabilitation program : day 60)
  • Quality of life : follow-up(Quality of life is assessed 3 month after the end of the rehabilitation program : day 150)
  • Anxiety and depression : baseline(Anxiety and depression are assessed at the beginning of the rehabilitation program : day 0)
  • Anxiety and depression : follow up(Anxiety and depression are assesses 3 month after the end of pulmonary rehabilitation program : day 150)
  • Quality of life : baseline(Quality of life is assessed at the beginning of the rehabilitation program : day 0)
  • Functional capacity (six-minute walk test) : baseline(Functional capacity is assessed at the beginning of the rehabilitation program : day 0)
  • Relation between the cognitive function and the respiratory function (forced expiratory volume in 1 second)(The relation is assessed between baseline demographic data at day 0)
  • Adherence(Adherence is assessed at the end of the rehabilitation program : day 60)

Study Sites (2)

Loading locations...

Similar Trials